Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Restructuring Costs (2021 - 2025)

Historic Restructuring Costs for Cellebrite DI (CLBT) over the last 5 years, with Q3 2025 value amounting to $164000.0.

  • Cellebrite DI's Restructuring Costs fell 2264.15% to $164000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $385000.0, marking a year-over-year increase of 1846.15%. This contributed to the annual value of $221000.0 for FY2024, which is 39111.11% up from last year.
  • Per Cellebrite DI's latest filing, its Restructuring Costs stood at $164000.0 for Q3 2025, which was down 2264.15% from $212000.0 recorded in Q3 2024.
  • Over the past 5 years, Cellebrite DI's Restructuring Costs peaked at $1.2 million during Q4 2021, and registered a low of -$323000.0 during Q2 2023.
  • For the 5-year period, Cellebrite DI's Restructuring Costs averaged around $297250.0, with its median value being $188000.0 (2024).
  • As far as peak fluctuations go, Cellebrite DI's Restructuring Costs plummeted by 18197.97% in 2023, and later surged by 30769.23% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Restructuring Costs stood at $1.2 million in 2021, then tumbled by 88.7% to $133000.0 in 2022, then tumbled by 60.9% to $52000.0 in 2023, then surged by 307.69% to $212000.0 in 2024, then decreased by 22.64% to $164000.0 in 2025.
  • Its Restructuring Costs stands at $164000.0 for Q3 2025, versus $212000.0 for Q3 2024 and $9000.0 for Q1 2024.